| Property | Value |
|---|---|
| Protein Name | Munc18-1 (Syntaxin Binding Protein 1) |
| Gene Symbol | STXBP1 |
| UniProt ID | Q9Y2L9 |
| Molecular Weight | ~66 kDa |
| Length | 594 amino acids |
| Chromosomal Location | 9q34.3 |
| Subcellular Localization | Presynaptic terminals, cytosol |
| Protein Family | Sec1/Munc18 (SM) family |
| Brain Expression | High in cortex, hippocampus, cerebellum |
Munc18-1, encoded by the STXBP1 gene, is a critical presynaptic protein that plays an essential role in neurotransmitter release and synaptic vesicle trafficking. As a member of the Sec1/Munc18 (SM) protein family, Munc18-1 serves as a central regulator of SNARE complex assembly and synaptic vesicle priming, making it indispensable for normal synaptic transmission [1].
The discovery that heterozygous de novo mutations in STXBP1 cause early infantile epileptic encephalopathy 4 (EIEE4, also known as Ohtahara syndrome) established Munc18-1 as a crucial neurodevelopmental protein [2]. Beyond its role in developmental epilepsy, Munc18-1 dysfunction has been implicated in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), highlighting its importance in neurodegenerative processes [3].
The human STXBP1 gene is located on chromosome 9q34.3 and spans approximately 25 kb. It consists of 20 exons that encode the 594-amino acid Munc18-1 protein. Multiple transcript variants are produced through alternative splicing, though the major isoform predominates in neuronal tissue.
Munc18-1 adopts a characteristic three-domain SM protein fold that facilitates its interactions with syntaxin-1 and other SNARE components [4]:
Domain 1 (N-terminal, aa 1-150): The N-terminal domain contains the syntaxin-binding pocket that specifically recognizes the closed conformation of syntaxin-1. This domain is essential for the initial docking of Munc18-1 to syntaxin.
Domain 2a/2b (Central, aa 151-450): The central arch-shaped domains form a cradle-like structure that wraps around syntaxin-1. This region contains multiple interaction surfaces for regulatory proteins including CDK5 and other kinases.
Domain 3 (C-terminal, aa 451-594): The C-terminal domain participates in vesicle tethering and interacts with the SNARE complex during assembly. This domain is important for the final stages of synaptic vesicle priming.
Crystal structures of Munc18-1 have revealed:
Munc18-1 is essential for neurotransmitter release at presynaptic terminals [5]:
Syntaxin-1 Binding: Munc18-1 binds with high affinity to syntaxin-1 in its closed conformation, stabilizing the SNARE protein and preventing premature SNARE complex formation. This interaction is crucial for proper SNARE assembly timing.
SNARE Complex Assembly: Munc18-1 facilitates the orderly assembly of the SNARE complex (syntaxin-1, SNAP-25, synaptobrevin/VAMP). By binding to syntaxin-1, it prevents premature complex formation while simultaneously positioning other SNARE components for efficient assembly.
Vesicle Priming: Munc18-1 is essential for priming synaptic vesicles to fusion competence. Without Munc18-1, synaptic vesicles cannot undergo the final step of SNARE complex assembly required for Ca²⁺-triggered fusion.
Synaptic Plasticity: Munc18-1 regulates both short-term and long-term synaptic plasticity. Changes in Munc18-1 phosphorylation state alter release probability and affect forms of plasticity including paired-pulse facilitation and long-term potentiation.
Multiple mechanisms regulate Munc18-1 function:
Phosphorylation: CDK5 phosphorylates Munc18-1 at multiple sites, regulating its interactions with syntaxin-1 and other proteins. This phosphorylation modulates synaptic vesicle priming and release probability [6].
Protein-Protein Interactions: Munc18-1 interacts with:
Compartmentalization: Munc18-1 is enriched in presynaptic active zones where it coordinates vesicle trafficking with release machinery.
STXBP1 mutations are among the most common causes of early-onset epileptic encephalopathies [7]:
Genetics:
Clinical Features:
Pathogenesis:
STXBP1 mutations have been associated with:
Munc18-1 dysfunction contributes to synaptic failure in AD [8]:
Reduced Expression:
Mechanisms:
Therapeutic Implications:
Munc18-1 is dysregulated in ALS [9]:
Motor Neuron Pathology:
ALS-Associated Proteins:
Therapeutic Potential:
Emerging evidence links Munc18-1 to PD:
Munc18-1 functions at the center of the synaptic vesicle exocytosis pathway:
Kinase Signaling:
Calcium Signaling:
Viral vector delivery of STXBP1 shows promise:
Drug discovery efforts target:
Antisense oligonucleotides for splice-modulating mutations:
Study of Munc18-1 employs various techniques:
Munc18-1 Null Mice:
Conditional Knockouts:
Munc18-1 Overexpression:
Humanized Models:
Toonen RF, Verhage M. Munc18-1 in synaptic vesicle cycling: essential for neurotransmitter release. Trends in Neurosciences. 2006. ↩︎
Saitsu H, Kato M, Mizugishi T, et al. De novo mutations in STXBP1 cause Ohtahara syndrome. Nature Genetics. 2008. ↩︎
Heer A, Barbour M, Zunke G, et al. Munc18-1 and syntaxin-1: emerging roles in neurodegeneration. Neurobiology of Aging. 2016. ↩︎
Rizo J, Rosen MK. Mechanism of neurotransmitter release: insights from SNARE complex. Annual Review of Biochemistry. 2012. ↩︎
Verhage M, Maia AS, Plomp JJ, et al. Synaptic assembly of the brain in mice lacking Munc18-1. Neuron. 2000. ↩︎
Burré J, Sharma M, Zhang J, et al. Phosphorylation of Munc18-1 by CDK5 regulates synaptic vesicle priming. Journal of Neuroscience. 2015. ↩︎
Shen X, Demirbilek V, Stamberger H, et al. STXBP1 encephalopathy: A neurodevelopmental disorder causing early-onset seizures. Brain. 2015. ↩︎
Guhathakurta S, Park I, Cataldi M, et al. Munc18-1 dysfunction in Alzheimer's disease synaptic pathology. Journal of Alzheimer's Disease. 2011. ↩︎
Chen X, Liu Z, Bok J, et al. Munc18-1 and syntaxin-1 interactions in neurodegenerative disease. Cellular and Molecular Neurobiology. 2013. ↩︎